5 days ago
Biological E, Recbio ink pact to make HP9 vax in India
HYDERABAD: Biopharma company Biological E Ltd (BE) entered into a licensing cooperation agreement with Chinese biopharma player Jiangsu Recbio Technology Company Limited for the latter's recombinant 9-valent Human Papillomavirus (HPV9) vaccine, REC603.
The HPV9 vaccine has been designed to protect against nine types of HPV, including those responsible for cervical, vulvar, vaginal, anal, and oropharyngeal cancers, as well as genital warts.
As part of the agreement, Recbio will provide BE with the drug substance (DS) and transfer technology to formulate, fill, and package vaccines. BE will get exclusive rights to commercialise the vaccine in India and also participate in United Nations Children's Fund (UNICEF) and Pan American Health Organisation (PAHO) tenders in other markets.
You Can Also Check:
Hyderabad AQI
|
Weather in Hyderabad
|
Bank Holidays in Hyderabad
|
Public Holidays in Hyderabad
Get the latest lifestyle updates on Times of India, along with
Doctor's Day 2025
,
messages
and quotes!
